OSR Health (OSRH) Plunges After Nasdaq Delisting Determination; Company Plans to Appeal

The Quick Take

• OSR Health (OSRH) received a Nasdaq delisting determination for its common stock and warrants, sending shares sharply lower.
• The company is appealing the delisting decision, which halts the process during the appeal period.
• Failure to meet Nasdaq listing requirements is typically driven by minimum bid price violations or financial threshold breaches.

OSR Health has received a written Staff Delisting Determination from the Nasdaq Listing Qualifications Department, initiating a formal process to delist both the company's common stock and warrants from the Nasdaq exchange. Shares plunged on the news, reflecting the severe market reaction to delisting risk — stocks that move to OTC markets typically lose significant institutional investor access and suffer further valuation compression as compliance-constrained investors are forced to exit. The company has indicated its intention to appeal the determination, a process that typically buys 45-180 days while maintaining listing status.

Nasdaq delisting determinations are typically triggered by failure to meet minimum bid price requirements (stock trading below $1 for an extended period), minimum stockholder equity thresholds, or net income and revenue listing standards. For healthcare companies like OSR Health that are pre-revenue or early-revenue, financial threshold requirements are the most common delisting trigger. The appeal process gives the company time to execute a compliance plan — most commonly a reverse stock split to restore the minimum bid price, or a capital raise to meet equity requirements.

Investors in OSR Health face a binary outcome over the appeal timeline: successful compliance restoration (reverse split, equity raise, or operational milestones) that keeps the Nasdaq listing, or a failed appeal resulting in delisting to the OTC Pink Sheets. The warrants — which also received a delisting determination — add further complexity, as warrant value is contingent on the underlying stock maintaining a viable exchange listing. Monitor OSR Health's appeal hearing schedule and any SEC filings disclosing compliance plans, capital structure changes, or reverse stock split proposals.

Synthesized from 1 source.